Sunrise Realty Trust Announces ISS and Glass Lewis Support for Merger-Related Proposals Globe Newswire · Oct 13, 2026
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth Globe Newswire · Oct 13, 2026
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026 Globe Newswire · Oct 12, 2026
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss Globe Newswire · Oct 11, 2026
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD) Globe Newswire · Oct 10, 2026
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call Cision · Oct 10, 2026
Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026 Cision · Oct 10, 2026
Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences Globe Newswire · Oct 9, 2026
